Does the neuropeptide somatostatin have therapeutic potential against schistosomiasis?

Trends in Parasitology

Volumn 18, Issue 7, 2002, Pages 295-298

  Chatterjee, Shyama ^a   Mbaye, Amadou ^b   De Man, Joris G ^a   Van Marck, Eric A E ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Centre Hospitalier Régional de Saint Louis   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; NEUROPEPTIDE; OCTREOTIDE; PROPRANOLOL; SOMATOSTATIN;

CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; ESOPHAGUS VARICES; HUMAN; IMMUNOMODULATION; LIVER FIBROSIS; MORBIDITY; NONHUMAN; PATHOGENESIS; PORTAL VEIN BLOOD PRESSURE; REVIEW; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; T LYMPHOCYTE; TREATMENT INDICATION; TREATMENT OUTCOME;

AMINO ACID SEQUENCE; ANIMALS; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; SCHISTOSOMA; SCHISTOSOMIASIS; SOMATOSTATIN;

SCHISTOSOMA; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; TREMATODA;

EID: 0036629777     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4922(02)02294-8     Document Type: Review

References (34)

1. Chatterjee S., Van Marck E. The role of somatostatin in schistosomiasis: a basis for immunomodulation in host-parasite interactions? Trop. Med. Int. Health. 6:2001;578-581.
2. Chatterjee S., et al. Somatostatin and intestinal schistosomiasis: therapeutic and neuropathological implications in host-parasite interactions. Trop. Med. Int. Health. 6:2001;1008-1015.
3. WHO Expert Committee. The control of schistosomiasis. WHO Tech. Rep. Ser. 830:1993;1-86.
4. Symmers W.S. Note on a new form of liver cirrhosis due to the presence of the ova of Bilharzia haematobia. J. Pathol. Bacteriol. 9:1904;237-239.
5. WHO Workshop Report (2000) Ultrasound in schistosomiasis: a practical guide to the standardized use of ultrasonography for assessment of schistosomiasis-related morbidity. TDR/STR/SCH/00.1, 1-49
6. Domingo E.O., Warren K.S. Pathology and pathophysiology of the small intestine in murine schistosomiasis mansoni, including a review of the literature. Gastroenterology. 56:1969;231-240.
7. Moreels T.G., et al. Effect of Schistosoma mansoni-induced granulomatous inflammation of murine gastrointestinal motility. Am. J. Physiol. 280:2001;G1030-G1042.
8. Chen M.G., Mott K.E. Progress in assessment of morbidity to Schistosoma mansoni infection. A review of recent literature. Trop. Dis. Bull. 85:1988;RI-R56.
9. Gryseels B. Morbidity due to infection with Schistosoma mansoni: an update. Trop. Geogr. Med. 44:1992;189-200.
10. Reynaert H., et al. Activated rat hepatic stellate cells express somatostatin receptor subtypes 1, 2 and 3. Hepatology. 30:1999;236A.
11. Reynaert H., et al. Somatostatin suppresses Endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology. 121:2001;915-930.
12. Blum A.M., et al. Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-γ secretion. J. Immunol. 149:1992;3621-3626.
13. Elliott D.E., et al. SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-γ release. Eur. J. Immunol. 29:1999;2454-2463.
14. Elliott D.E., Weinstock J.V. Granulomas in murine Schistosomiasis mansoni have a somatostatin immunoregulatory circuit. Metabolism. 45:(Suppl.):1996;88-90.
15. Elliott D.E., et al. T lymphocytes isolated from the hepatic granulomas of schistosome-infected mice express somatostatin receptor subtype II (SSTR2) messenger RNA. J. Immunol. 153:1994;1180-1186.
16. Weinstock J.V., Elliott D. The somatostatin immunoregulatory circuit present at sites of chronic inflammation. Eur. J. Endocrinol. 143:(Suppl. 1):2000;S15-S19.
17. Weinstock J.V., Elliott D. The substance P and somatostatin interferon-gamma immunoregulatory circuit. Ann. New York Acad. Sci. 840:1998;532-539.
18. Weinstock J.V., et al. Macrophages within the granulomas of murine Schistosoma mansoni are a source of a somatostatin 1-14-like molecule. Cell. Immunol. 131:1990;381-390.
19. Jacobs W., et al. Adult Schistosoma mansoni worms positively modulate soluble egg antigen-induced inflammatory granuloma formation in vivo. Stereological analysis and immunophenotyping of extracellular matrix proteins, adhesion molecules, and chemokines. Am. J. Pathol. 150:1997;2033-2045.
20. Cheever A.W., et al. Kinetics of egg production and egg excretion by Schistosoma mansoni and S. japonicum in mice infected with a single pair of worms. Am. J. Trop. Med. Hyg. 50:1994;281-295.
21. Wyler D.J. Why does liver fibrosis occur in schistosomiasis? Parasitol. Today. 8:1992;277-279.
22. Wyler D.J. Molecular and cellular basis of hepatic fibrogenesis in experimental Schistosomiasis mansoni infection. Mem. Inst. Oswaldo Cruz. 87:1992;117-125.
23. Reichlin S. Somatostatin. Part One. New Engl. J. Med. 309:1983a;1495-1501.
24. Reichlin S. Somatostatin. Part Two. New Engl. J. Med. 309:1983b;1556-1563.
25. Scarpignato C. Somatostatin in digestive diseases: improving the treatment options. Scarpignato C., Digestion. 60:1999;1-72 Karger.
26. Avgerinos A., et al. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet. 350:1997;1495-1499.
27. Cheever A.W., Deb S. Persistence of hepatic fibrosis and tissue eggs following treatment of Schistosoma japonicum infected mice. Am. J. Trop. Med. Hyg. 40:1989;620-628.
28. el Tourabi H., et al. Propanolol reduces mortality in patients with portal hypertension secondary to schistosomiasis. Ann. Trop. Med. Parasitol. 88:1994;493-500.
29. Gryseels B. Human resistance to Schistosoma infections - age or experience. Parasitol. Today. 10:1994;380-384.
30. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin. Liver Dis. 10:1990;1-10.
31. Rockey D.C., et al. Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma. Hepatology. 16:1992;776-784.
32. Reynaert H., et al. Effect of somatostatin-14 on extracellular matrix expression by activated rat hepatic stellate cells. J. Hepatol. 34:2001;6.
33. Chatterjee S., et al. Severe morbidity caused by Schistosoma mansoni in Northern Senegal: Does the neuropeptide hormone somatostatin determine morbidity? Acta Gastro-Enterologica Belgica. 64:2001;A05.
34. Mansy S.S., et al. Effect of octreotide on the pathology of hepatic schistosomiasis. Arzneimittelforschung. 48:1998;855-861.